Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 4:2018:5076259.
doi: 10.1155/2018/5076259. eCollection 2018.

Optimizing the Delivery of Inhaled Medication for Respiratory Patients: The Role of Valved Holding Chambers

Affiliations
Review

Optimizing the Delivery of Inhaled Medication for Respiratory Patients: The Role of Valved Holding Chambers

R Andrew McIvor et al. Can Respir J. .

Abstract

Valved holding chambers (VHCs) have been used with pressurized metered-dose inhalers since the early 1980s. They have been shown to increase fine particle delivery to the lungs, decrease oropharyngeal deposition, and reduce side effects such as throat irritation, dysphonia, and oral candidiasis that are common with use of pressurized metered-dose inhalers (pMDIs) alone. VHCs act as aerosol reservoirs, allowing the user to actuate the pMDI device and then inhale the medication in a two-step process that helps users overcome challenges in coordinating pMDI actuation with inhalation. The design of VHC devices can have an impact on performance. Features such as antistatic properties, effective face-to-facemask seal feedback whistles indicating correct inhalation speed, and inhalation indicators all help improve function and performance, and have been demonstrated to improve asthma control, reduce the rate of exacerbations, and improve quality of life. Not all VHCs are the same, and they are not interchangeable. Each pairing of a pMDI device plus VHC should be considered as a unique delivery system.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Valved holding chamber featuring an inhalation indicator.
Figure 2
Figure 2
Lung deposition of inhaled medication is improved with perfect pMDI technique and with valved holding chamber. (a) Inhaler alone with perfect technique. (b) Inhaler alone with poor technique. (c) Inhaler with valved holding chamber.

Comment in

References

    1. Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention. September 2017. http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-managem...
    1. Global Strategy for the Diagnosis. Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. September 2017. http://goldcopd.org.
    1. Stein S. W., Thiel C. G. The history of therapeutic aerosols: a chronological review. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2017;30(1):20–41. doi: 10.1089/jamp.2016.1297. - DOI - PMC - PubMed
    1. Lavorini F., Fontana G. A. Targeting drugs to the airways: the role of spacer devices. Expert Opinion on Drug Delivery. 2009;6(1):91–102. doi: 10.1517/17425240802637862. - DOI - PubMed
    1. Levy M. L., Hardwell A., McKnight E., Holmes J. Asthma patients’ inability to use a pressurized metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis. Primary Care Respiratory Journal. 2013;22(4):406–411. doi: 10.4104/pcrj.2013.00084. - DOI - PMC - PubMed

MeSH terms

Substances